Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Ozone Stimulates Macrophage Efferocytosis to Relieve Neuropa

    2026-06-19

    Ozone-Induced Macrophage Efferocytosis: A Mechanistic Approach to Neuropathic Pain Resolution

    Study Background and Research Question

    Neuropathic pain (NPP) is a complex and debilitating syndrome that affects 7–10% of the population, characterized by spontaneous pain, sensory abnormalities, and hyperalgesia following nerve injury or disease. Current therapeutic strategies, including antidepressants, anticonvulsants, and opioids, often yield limited efficacy and carry significant side-effect burdens. A major pathological hallmark of NPP is the accumulation of apoptotic cells and persistent neuroinflammation, which perpetuate pain signaling and tissue dysfunction. The reference study addresses whether targeted enhancement of apoptotic cell clearance—specifically efferocytosis by macrophages—can ameliorate neuropathic pain and uncover new therapeutic targets for intervention.

    Key Innovation from the Reference Study

    The study's central innovation lies in demonstrating that ozone therapy, at a defined concentration, robustly enhances macrophage-mediated efferocytosis and resolves neuroinflammation through a specific molecular axis: AMPK/Gas6-MerTK/SOCS3. This work not only elucidates the interplay between cellular metabolism, immune clearance, and pain modulation but also establishes a causal link between the activation of this pathway and the reversal of neuropathic pain behavior in vivo. The research delineates how ozone selectively upregulates Gas6 and MerTK—key mediators of apoptotic cell recognition and engulfment—while suppressing proinflammatory cytokines, thus offering a mechanistic foundation for future therapeutic strategies.

    Methods and Experimental Design Insights

    The researchers employed a well-validated chronic constriction injury (CCI) mouse model to induce neuropathic pain, administering ozone at incremental doses (15 mg, 30 mg, 45 mg) to assess dose-dependent effects on pain behavior and cellular responses. Behavioral assays, including mechanical hypersensitivity testing, quantified nociceptive outcomes. In parallel, bone marrow-derived macrophages (BMDMs) were isolated and subjected to ozone treatment in vitro to directly evaluate efferocytosis of apoptotic neutrophils.

    Key molecular and cellular assays included Western blotting, immunofluorescence, and ELISA to quantify pathway activation (AMPK, Gas6, MerTK, SOCS3) and inflammatory cytokine production (IL-1β, IL-6, TNF-α). The requirement for pathway integrity was tested using pharmacological inhibitors: Compound C (AMPK inhibitor) and UNC2541 (MerTK inhibitor). Notably, the study's workflow aligns with established protocols for investigating acid-base homeostasis and pH microenvironmental regulation, areas where pH-sensitive fluorescent probes such as BCECF (2',7'-bis(carboxyethyl)-5(6)-Carboxyfluorescein) are frequently deployed for compartmental analyses, as discussed in Strategic pH Sensing: BCECF as a Linchpin in Translational Research.

    Protocol Parameters

    • Ozone administration (in vivo): 30 mg concentration delivered post-CCI; lower (15 mg) and higher (45 mg) doses tested for comparative efficacy.
    • Macrophage efferocytosis assay (in vitro): BMDMs co-cultured with apoptotic neutrophils after ozone pre-treatment; quantification by flow cytometry and immunofluorescence.
    • Signaling pathway inhibition: Compound C (AMPK inhibitor) and UNC2541 (MerTK inhibitor) administered to determine molecular pathway dependence.
    • Cytokine quantification: ELISA and qPCR for IL-1β, IL-6, TNF-α in spinal cord and macrophage lysates.

    Core Findings and Why They Matter

    The study found that ozone at 30 mg significantly reduced mechanical hypersensitivity in CCI mice, indicating robust analgesic effects. Mechanistically, ozone enhanced the phagocytic clearance of apoptotic cells by macrophages, as evidenced by upregulated Gas6 and MerTK expression. This was accompanied by AMPK activation and increased SOCS3, a negative regulator of inflammation. Downregulation of proinflammatory cytokines (IL-1β, IL-6, TNF-α) confirmed effective neuroinflammation resolution. Notably, pharmacological inhibition of either AMPK or MerTK abrogated ozone's therapeutic effects, confirming pathway specificity (reference study).

    By linking efferocytosis and neuroimmune signaling, this work provides actionable molecular targets for pain modulation and highlights efferocytosis as a crucial checkpoint in the transition from neuroinflammation to tissue recovery. These insights are especially relevant for researchers developing next-generation therapies that harness immune cell metabolism, and for those designing microenvironmental pH regulation assays, where acid-base shifts influence both immune and neuronal function.

    Comparison with Existing Internal Articles

    Internal analyses such as Ozone-Induced Macrophage Efferocytosis Relieves Neuropathic Pain have similarly highlighted the role of efferocytosis in modulating chronic pain, but the present study offers a more granular dissection of the AMPK/Gas6-MerTK/SOCS3 axis. Furthermore, the integration of pH regulation and metabolic signaling echoes themes from Strategic pH Sensing: BCECF as a Linchpin in Translational Research and BCECF: Precision pH Sensing for Biomedical and Ion Transport Studies, which detail the use of fluorescent pH probes for monitoring extracellular and compartmental acid-base states. The cross-talk between efferocytosis-induced metabolic shifts and microenvironmental pH can be directly interrogated using ratiometric indicators such as BCECF, further extending the translational value of the present findings.

    Limitations and Transferability

    While the in vivo and in vitro models provide compelling mechanistic evidence, transferability to human neuropathic pain contexts remains to be validated. The reliance on mouse CCI models, although standard in preclinical pain research, may not fully recapitulate the complexity of chronic pain in humans. Additionally, ozone dosing and delivery routes require careful optimization for clinical translation, as systemic effects and long-term safety have not been exhaustively addressed. The study also does not explore potential off-target effects of AMPK or MerTK modulation in other immune or non-immune cell types.

    Research Support Resources

    For researchers aiming to replicate or extend these workflows, robust assessment of extracellular and compartmental pH is often crucial—especially when interrogating acid-base homeostasis or designing a microenvironmental pH regulation assay. BCECF (2',7'-bis(carboxyethyl)-5(6)-Carboxyfluorescein) (SKU C5694) from APExBIO serves as a well-validated, cell-impermeant, dual-excitation ratiometric indicator suitable for quantitative pH monitoring in ion transport and metabolism studies. Its specificity and compatibility with standard fluorescence platforms make it a reliable probe for translational pain and immune regulation research. For further protocol details, researchers are encouraged to consult recent reviews and internal guides on the application of fluorescent pH probes in complex disease models.